These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6348752)

  • 1. Plasma prednisolone concentrations and kinetics in renal transplant patients.
    Nelson WE; Doherty CC; Douglas JF; McGeown MG; Delargy H; Temple DJ
    Proc Eur Dial Transplant Assoc; 1983; 19():544-51. PubMed ID: 6348752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Proc Eur Dial Transplant Assoc; 1983; 20():286-90. PubMed ID: 6361740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance of high dose prednisolone from plasma after renal transplantation.
    Park HS; Greene JA; Bacon GE
    Clin Nephrol; 1974; 2(1):18-23. PubMed ID: 4595979
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J
    Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
    Shibata N; Hoshino N; Minouchi T; Yamaji A; Park K; Tomoyoshi T; Abe H; Kodama M
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):202-9. PubMed ID: 9587046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
    Gambertoglio JG; Vincenti F; Feduska NJ; Birnbaum J; Salvatierra O; Amend WJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):561-5. PubMed ID: 6997330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
    Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
    Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
    Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt J; Danhof M; de Fijter JW; Guchelaar HJ
    Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation.
    Dresske B; Zavazava N; Jenisch S; Exner B; Lenz P; El Mokhtari NE; Kremer B; Faendrich F
    Transplantation; 2003 Apr; 75(8):1286-91. PubMed ID: 12717217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious renal transplant rejection and adrenal hypofunction after gradual withdrawal of prednisolone two years after transplantation.
    Naik RB; Chakraborty J; English J; Marks V; Slapak M; Lee HA
    Br Med J; 1980 Jun; 280(6228):1337-40. PubMed ID: 6992931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.
    Ost L; Björkhem I; von Bahr C
    Eur J Clin Pharmacol; 1984; 26(3):363-9. PubMed ID: 6376143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.
    Bergmann TK; Isbel NM; Ostini R; Barraclough KA; Campbell SB; McWhinney BC; Inder WJ; Russell A; Staatz CE
    Clin Drug Investig; 2015 Nov; 35(11):743-50. PubMed ID: 26403249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.
    Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ
    Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.